drugset / Trial / NCT00835159

Rivastigmine in the Treatment of Postoperative Delirium: a Pilot Clinical Trial

NCT00835159

Phase 4 Completed 30 enrolled NYU Langone Health Novartis · collab
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to determine whether preoperative administration of Rivastigmine prevents the incidence of postoperative delirium in patients undergoing major surgery as well as postoperative cognitive dysfunction.

Timeline

Start
2008-12
Primary completion
2010-07
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Rivastigmine Small molecule 4.6 mg Other

Indications